169 related articles for article (PubMed ID: 19675167)
41. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
[TBL] [Abstract][Full Text] [Related]
42. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Zhang X; Izikson L; Liu L; Weiner HL
J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
[TBL] [Abstract][Full Text] [Related]
43. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
[TBL] [Abstract][Full Text] [Related]
44. Antigen controls IL-7R alpha expression levels on CD8 T cells during full activation or tolerance induction.
Hammerbeck CD; Mescher MF
J Immunol; 2008 Feb; 180(4):2107-16. PubMed ID: 18250416
[TBL] [Abstract][Full Text] [Related]
45. The quantity of TCR signal determines positive selection and lineage commitment of T cells.
Watanabe N; Arase H; Onodera M; Ohashi PS; Saito T
J Immunol; 2000 Dec; 165(11):6252-61. PubMed ID: 11086060
[TBL] [Abstract][Full Text] [Related]
46. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
[TBL] [Abstract][Full Text] [Related]
47. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
Degermann S; Pria E; Adorini L
J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
[TBL] [Abstract][Full Text] [Related]
48. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
[TBL] [Abstract][Full Text] [Related]
49. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
50. Exclusion and inclusion of TCR alpha proteins during T cell development in TCR-transgenic and normal mice.
Lacorazza HD; Nikolich-Zugich J
J Immunol; 2004 Nov; 173(9):5591-600. PubMed ID: 15494509
[TBL] [Abstract][Full Text] [Related]
51. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.
Isomäki P; Panesar M; Annenkov A; Clark JM; Foxwell BM; Chernajovsky Y; Cope AP
J Immunol; 2001 May; 166(9):5495-507. PubMed ID: 11313388
[TBL] [Abstract][Full Text] [Related]
52. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
Kerry SE; Buslepp J; Cramer LA; Maile R; Hensley LL; Nielsen AI; Kavathas P; Vilen BJ; Collins EJ; Frelinger JA
J Immunol; 2003 Nov; 171(9):4493-503. PubMed ID: 14568922
[TBL] [Abstract][Full Text] [Related]
53. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
[TBL] [Abstract][Full Text] [Related]
54. Immune tolerance induced by polyethylene glycol-conjugate of protein antigen: clonal deletion of antigen-specific Th-cells in the thymus.
Saito T; Kumagai Y; Hiramatsu T; Kurosawa M; Sato T; Habu S; Mitsui K; Kodera Y; Hiroto M; Matsushima A; Inada Y; Nishimura H
J Biomater Sci Polym Ed; 2000; 11(6):647-56. PubMed ID: 10981679
[TBL] [Abstract][Full Text] [Related]
55. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
56. Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance.
Orr SJ; Roessler S; Quigley L; Chan T; Ford JW; O'Connor GM; McVicar DW
J Immunol; 2010 Aug; 185(3):1393-403. PubMed ID: 20592278
[TBL] [Abstract][Full Text] [Related]
57. Rai acts as a negative regulator of autoimmunity by inhibiting antigen receptor signaling and lymphocyte activation.
Savino MT; Ortensi B; Ferro M; Ulivieri C; Fanigliulo D; Paccagnini E; Lazzi S; Osti D; Pelicci G; Baldari CT
J Immunol; 2009 Jan; 182(1):301-8. PubMed ID: 19109161
[TBL] [Abstract][Full Text] [Related]
58. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
[TBL] [Abstract][Full Text] [Related]
59. CD8
Gröschel C; Sasse A; Monecke S; Röhrborn C; Elsner L; Didié M; Reupke V; Bunt G; Lichtman AH; Toischer K; Zimmermann WH; Hasenfuß G; Dressel R
Front Immunol; 2018; 9():2665. PubMed ID: 30498501
[TBL] [Abstract][Full Text] [Related]
60. Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.
Gatzka M; Newton RH; Walsh CM
J Immunol; 2009 Jul; 183(1):285-97. PubMed ID: 19542440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
